Huahao Zhongtian Pharmaceuticals-B: The auditor expects to issue a qualified opinion in the audit report.

2026-04-01 09:26:06

China Haotian Pharmaceutical-B Announcement, the company’s board of directors has notified shareholders and potential investors that, during the review of the company’s consolidated financial statements for the year ended December 31, 2025, the company’s auditor stated that it is expected that a qualified opinion will be issued in the audit report. The company is in discussion with the auditor to resolve the relevant matters. Further details will be disclosed in the annual results announcement. Shareholders and potential investors are advised to exercise caution when trading the company’s shares.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

2 Likes